Skip to main content
TipRanks
Go Ultimate75% OFF

Sana Biotechnology (SANA) Financial Statements

904 Followers

Sana Biotechnology Financial Overview

Sana Biotechnology's market cap is currently $605.26M. The company's EPS TTM is $-0.53; its P/E ratio is -3.81; Sana Biotechnology is estimated to report earnings on March 23, 2027, and the estimated EPS forecast is $-0.16. See an overview of income statement, balance sheet, and cash flow financials.

Financial overview
Dec 25Dec 24Dec 23Dec 22Dec 21
Income Statement
Total Revenue$ 0.00$ 0.00$ 0.00$ 0.00$ 0.00
Gross Profit$ -12.75M$ 0.00$ 0.00$ 0.00$ 0.00
Operating Income$ -190.96M$ -272.72M$ -293.14M$ -272.56M$ -356.91M
EBITDA$ -231.42M$ -251.26M$ -258.70M$ -253.85M$ -344.86M
Net Income$ -244.17M$ -266.76M$ -283.25M$ -269.48M$ -355.93M
Balance Sheet
Cash & Short-Term Investments$ 138.38M$ 152.50M$ 205.19M$ 423.96M$ 551.00M
Total Assets$ 416.89M$ 501.02M$ 565.30M$ 822.72M$ 1.13B
Total Debt$ 78.86M$ 94.20M$ 104.10M$ 108.25M$ 110.94M
Net Debt$ 6.99M$ -33.37M$ -29.42M$ -68.51M$ -142.09M
Total Liabilities$ 256.01M$ 250.52M$ 277.79M$ 323.40M$ 400.90M
Stockholders' Equity$ 160.88M$ 250.50M$ 287.51M$ 499.31M$ 728.50M
Cash Flow
Free Cash Flow$ -144.77M$ -256.58M$ -273.61M$ -310.93M$ -280.92M
Operating Cash Flow$ -143.83M$ -223.15M$ -253.58M$ -290.05M$ -251.05M
Investing Cash Flow$ -40.24M$ 17.45M$ 172.01M$ 210.56M$ -245.80M
Financing Cash Flow$ 128.73M$ 199.75M$ 31.65M$ 4.91M$ 631.75M

Currency in USD

Sana Biotechnology Earnings and Revenue History

-450M-300M-150M00 %0.4 %0.8 %1.2 %EarningsProfit Margin20182019202020212022202320242025RevenueEarningsProfit Margin

Sana Biotechnology Liabilities to Assets

0500M1B1.5B0 %60 %120 %180 %LiabilitiesLiabilities to Assets20182019202020212022202320242025AssetsLiabilitiesLiabilities to Assets

Sana Biotechnology Cash Flow

-500M-250M0250M500M750M20182019202020212022202320242025OperatingInvestingFinancing

Sana Biotechnology Forecast EPS vs Actual EPS

-0.3-0.2-0.100.10.2Q3 25Q4 25Q1 26Q2 26Q3 26Q4 26EPS EstimateBeatMiss